2026 NPPES data Pharmacist NPI 1396066437
Verify on CMS →

Mercedeh Kalantari-Nazari

Pharmacist in La Crescenta, California. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers — including 290,447 in Pharmacist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration — see our methodology.

Federal data — no proprietary rating. We show these CMS records as-is — no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
195
Medicare Part D claims · 161 beneficiaries · Pharmacist avg: 135
Generic prescribing
0%
generic claims · >99% brand-name · higher generic rates reduce patient out-of-pocket costs
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Mercedeh Kalantari-Nazari filed 195 Medicare Part D claims in 2023 as a Pharmacist in La Crescenta, California, prescribing 0% generic.

195
Part D claims, 2023
0%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

Mercedeh Kalantari-Nazari's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

195 35th percentile higher than 35% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about Mercedeh Kalantari-Nazari?

Quality data not reported

NPI registry status

Active

Issued 06/11/2010

NPI 1396066437

Primary specialty

Pharmacist

High-volume

290,447 US NPIs in this specialty

Medicare Part D claims

195 44% vs specialty avg

2023 prescription claims

Specialty avg: 135

Specialty distribution in California

How Pharmacist compares to other specialties among California providers

California providers

Largest specialties in California (% of in-state providers)

Behavior Technician - 17.3%Behavior Technician17.3%Marriage & Family Therapist - 5.5%Marriage & Family Therapist5.5%Student in an Organized Health Care Education/Training Program - 5%Student in an Organized Health Care Education/Training Program5%Mental Health Counselor - 3.9%Mental Health Counselor3.9%Pharmacist - 3.5%Pharmacist3.5%Clinical Social Worker - 3.1%Clinical Social Worker3.1%
Largest specialties in California (% of in-state providers)

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacist ABMS/AOA estimate

Est. board-certified rate (Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Mercedeh Kalantari-Nazari appears in the CMS NPPES registry as a Pharmacist provider at 2647 FOOTHILL BLVD, La Crescenta, CA, 91214, with a listed phone of (818) 248-1016. NPI 1396066437 was issued on 06/11/2010. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Kalantari-Nazari most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 195 prescription claims written by this provider, covering 161 Medicare beneficiaries and totaling roughly $46K in drug spend, split >99% brand-name and 0% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacist is a high-volume specialty nationwide, with 290,447 enrolled providers across 56 states and an average of 135 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2647 FOOTHILL BLVD
La Crescenta, CA 91214

Provider Details

NPI 1396066437
Specialty Pharmacist
Gender Female
NPI Issued 06/11/2010

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to Mercedeh Kalantari-Nazari. To verify Mercedeh Kalantari-Nazari's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

Mercedeh Kalantari-Nazari — brand share 99.0%
Pharmacist average

>99% brand-name claims vs 0% generic, on 195 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

195
Total Claims
$46K
Total Drug Cost
161
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
195
Total Day Supply
209
Brand vs Generic
>99% brand / 0% generic
Brand Drug Cost
$46K

Patient Demographics

Average Patient Age
74.9 years
Avg HCC Risk Score
1.26
Gender Split
57% female / 43% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Shingrix
Varicella-Zoster Ge/As01b/Pf
81
Arexvy
Rsvpref3 Antigen/As01e/Pf
38
Abrysvo
"Rsv Vacc
N/A
Adacel Tdap
"Diph
N/A
Boostrix Tdap
"Diphth
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacist Overview

How Mercedeh Kalantari-Nazari fits within the Pharmacist landscape nationally.

290,447
Pharmacist Providers in US
56
States with Pharmacist
135
Avg Claims per Provider

Mercedeh Kalantari-Nazari's 195 claims are above the specialty average of 135.

Nearby Pharmacist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Kalantari-Nazari.

Compare Pharmacist nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry — providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the California medical board — federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Pharmacist peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only — they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Mercedeh Kalantari-Nazari's specialty?
Mercedeh Kalantari-Nazari specializes in Pharmacist and practices in La Crescenta, California.
How much does Mercedeh Kalantari-Nazari prescribe under Medicare Part D?
In 2023, Mercedeh Kalantari-Nazari wrote 195 Medicare Part D claims totaling $46K in drug costs for 161 beneficiaries.
Where is Mercedeh Kalantari-Nazari located?
Mercedeh Kalantari-Nazari is located at 2647 FOOTHILL BLVD, La Crescenta, CA, 91214. Phone: (818) 248-1016.
What is Mercedeh Kalantari-Nazari's NPI number?
Mercedeh Kalantari-Nazari's National Provider Identifier (NPI) is 1396066437, issued on 06/11/2010.
Does Mercedeh Kalantari-Nazari prescribe more brand-name or generic drugs?
Mercedeh Kalantari-Nazari's prescribing is >99% brand-name and 0% generic drugs by claim count, with $46K in brand drug costs.
How many Pharmacist providers are there in the US?
There are 290,447 Pharmacist providers across 56 states in the US. The average Pharmacist provider writes 135 Medicare Part D claims per year.
What drugs does Mercedeh Kalantari-Nazari prescribe most often?
Based on 2023 Medicare Part D data, Mercedeh Kalantari-Nazari's most frequently prescribed drugs include Shingrix, Arexvy, Abrysvo. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mercedeh Kalantari-Nazari accept Medicare?
Mercedeh Kalantari-Nazari appears in CMS Medicare data with 195 Part D claims and 161 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mercedeh Kalantari-Nazari's credentials?
Mercedeh Kalantari-Nazari's NPI is 1396066437. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.